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The  serum  of  certain  strains  of inbred mice lacks  a/~-globulin designated 
hc'  (1)  or MuB1  (2).  Absence of  the  protein  is accompanied  by a  complete 
deficiency of hemolytic complement  activity (1-3).  The  defect was  shown  to 
be genetically controlled (4, 5)  and the hypothesis was advanced that  the hc' 
or MuB1  protein represents a  component of complement (1, 2). Since the first, 
second,  third,  and fourth  component  of complement occur in normal concen- 
trations in the serum of complement-deficient mice (6,  7), the defect could only 
involve one of the five late acting components which  are now being referred to 
as C'5, C'6, C'7, C'8, and C'9 (8). 
In  the following it will be shown  that  mice with  an inherited  complement 
deficiency lack  the  fifth  component  of  complement,  or  C'5,  and  that  hc'  or 
MuB1  represents the murine analogue to human  C'5. Definition of the defect 
was afforded by the use of highly purified human  Ct5. This protein had previ- 
ously been isolated in this laboratory and characterized in terms of its physico- 
chemical and  irnmunochemical properties  (9). 
Materials and Methods 
Mouse Sera.--Serum and plasma used in this investigation were obtained from  animals 
of the age of 6 months or older. The following strains of mice were used as a source of com- 
plement-deficient  serum:  A/HeJ, DBA/2J, and B10.D2/Sn old line. Normal serum was ob- 
tained from C57L/J,  C57BL/6J,  DBA/1J,  B10.D2/Sn  new  line and  Swiss Webster mice. 
The animals were purchased  from the Jackson Laboratories, Bar Harbor, Maine. 
Sera to be used for quantitative precipitin analyses were purchased from Jackson Labora- 
tories. The blood was collected on ice-chilled Petri dishes, and the serum was separated from 
the clots after 30-55 rain at 0°C. The serum was shipped and stored at --00°C until used. 
For hemolytic studies,  blood was obtained from mice maintained in this laboratory. The 
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animals were bled from the retrobulbar plexus of the eye using a Pasteur pipette. The blood 
was immediately delivered into a test tube in an ice bath containing 0.5 ml veronal-buffered 
saline containing EDTA (sodium-ethylene-diamine  tetraacetic acid) in a 0.02 ~ concentration. 
After 1 ml mouse blood had been added to the tube, the plasma was separated by centrifuga- 
tion at 2°C.  The plasma obtained was considered to be diluted 1:2, taking into account a 
hematocrit of mouse blood of approximately 50%. The plasma was either used immediately 
or frozen and kept at  -70°C until used. When mouse plasma obtained in this manner was 
used for Whole complement analysis, it was recalcified immediately before use. Ten parts of 
plasma  were  mixed  with  one  part  of  a  solution  containing Ca  ++ and Mg  ++ in 0.03  and 
0.12 M concentration, respectively. 
Human  Serum  and  Purified  Human  Complement  Components.--Individual  human  sera 
from white donors were obtained from the San Diego Blood Bank, San Diego, Calif.  C'5 and 
C'3 were purified from human sera according to previously described methods (9).  Purified 
C'lq and partially purified C'6,  C'7,  C'8,  and  C'9 were obtained by procedures to be de- 
scribed elsewhere. 
Antisera.--Mouse  antisera were prepared against  MuB1  and  purified human  C'5.  The 
mice were injected subcutaneously with the antigen in complete Freund's adjuvant.  Each 
animal received 0.1 ml in the back and 0.05 ml in each of the rear foot-pads. Initially, injec- 
tions were given at 2-wk intervals, then at monthly intervals. Starting from the third injec- 
tion, blood was taken approximately 10 days after each injection. A total of eight injections 
was given and each animal was bled five times. The antisera were pooled before use. 
Mouse  Anti-MuBl.--(a)  20  male  and  5  female  A/HeJ  mice  were  immunized  with 
C57L/J male serum. Each animal received approximately 0.05 ml undiluted mouse serum per 
single injection. (b) 20  male DBA/2J mice were immunized with male DBA/I~[  serum in 
an identical manner. 
Mouse  Anti-Human  C'5.--20  male  and  5  female  A/HeJ  mice  were  immunized  with 
purified C'5.  Each animal received approximately 8  /zg antigen protein per injection. Pro- 
longed immunization led to the formation of smaU amounts of antibodies to human IgG and 
C'3. These antibodies were removed by appropriate adsorption. 
Rabbit  Anti-Human  C'5.--Rabbits  were  immunized  with  purified  C'5  as  described 
earlier (9). 
Immunodiffusion  and Immunodectrophorezis.--Double  diffusion  experiments, according to 
Ouchterlony, were performed on microscopic  slides in a  layer of 2.5 ml of 2% agar, or 1% 
agarose in veronal buffer, pH 8.6,  T/2  =  0.05.  Immunoelectrophoresis was performed ac- 
curding to Scheidegger in agar or agarose in the same buffer. 
Precipitin  Curves.--Antisera  used  for  quantitative  precipitation were  dialyzed  against 
PO4 buffer, pH 5.4, T/2  =  0.02, to remove the euglobulin  fraction. The pseudoglobulin frac- 
tion was dialyzed against veronal-buffered saline and stored at  --70°C until used. 0.2  ml of 
mouse anti-MuB1  or 0.05  ml of mouse anti-human C'5, both obtained from A/HeJ mice, 
were added to 3 ml conical test tubes containing an aliquot of the antigen and 0.125 ml 0.2 
EDTA. The volume of each tube was adjusted to 2.5 ml by the addition of 4% bovine albumin 
in veronal-buffered saline containing merthiolate 1/10,000.  After thorough mixing,  the tubes 
were incubated for 1 hr at 37°C and for 5 days at 4°C. The precipitates formed were separated 
from the supernatants after 30 min centrifugation at 1500 g, and subsequently washed three 
times with saline. The whole procedure was performed in the cold. The washed precipitate was 
finally  dissolved in 0.05 ml 0.1 N NaOH and the volume was adjusted to 0.1 ml with saline. 
The protein content of the precipitate was determined with the Folin method. 
The antigens were added either in the purified form, or contained in whole serum, or in 
serum which had been depleted of C'lq. The procedure to remove this component (i0)  in- 
evitably leads to some dilution of the serum. Since the precipitin curves were plotted in terms 
of undiluted serum, it was necessary to determine the degree of dilution following removal of 
C'lq. To this end, a small amount of 131I-labeled human C'3 was added to the serum and the UL~  R.  NILSSON AND  HANS  ~. M~LLER-EBERHARD 
dilution factor was calculated by comparing the radioactivity of the serum before and after 
processing. 
Prote~n Determinations.--Protein  was determined by a  modification of the Folin method 
(11).  Standard curves for human CP5 and IgG globulin were based on nitrogen analysis of 
these proteins. 
Dilucnts  and  Chdating Agents.--Veronal-buffered  saline  containing  Ca  ++  and  Mg  ++, 
with or without 0.1% gelatin (w/v), was used as diluent for complement assays. For the quan- 
titative  precipitin  analysis,  a  4%  (w/v)  bovine  serum  albumin  solution,  containing 
1/10,000 (w/v) of merthiolate in veronai-buffered saline lacking Ca  ++ and Mg  ++, was used 
as a diluent.  0.2 ~  EDTA solution, pH  7.6, was  prepared  by  mixing  7.44  g  Na~  EDTA 
with 7.60 g Na4  EDTA in a volume made up to 200 ml with distilled H~O. 
Hemolytic Activity  of the Late Acting,  Cation-Independent Components (C'3, C'5, C'6, C'7, 
Ct8,  C'9).--This was determined in 0.5  ml test systems containing l0  s EAC'la,4,2a  cells 
(intermediate complex consisting of sheep erythrocytes, E, rabbit antibody to sheep erythro- 
cytes, A, and the activated first, C'la, fourth, C'4, and activated second, CP2a, components 
of human complement) which were prepared by the phloridzin technique as described previ- 
ously  (9).  Alternatively,  EAC'la,4,2a  cells were  prepared  by  reacting  EA  with purified 
complement  components  according  to  methods  described  earlier  (12).  When  oxidized 
CJ2(oxycr2) was employed, oxidation was carried out by treating C'2 at a protein concentra- 
tion of approximately 1 mg/ml with 5 X  10  -5 M  Is in 2.5 X  10  ~  KI at 0°C for 5 rain.  This 
treatment was found to result in a  10-fold  enhancement of apparent C'2 hemolytic activity 
and in a  10 times greater stability of the EAC'la,4,2a complex  (13).  When prepared with 
°xyct2,  the latter intermediate complex is referred  to  as  EAC'la,4,oxy2a.  After washing 
twice, the cells were resuspended in gelatin-veronal-buffered saline and adjusted to a  2.5% 
suspension. The assay was carried out with EDTA present in the reaction mixture in a final 
concentration of 0.01 ~. 
In addition to determining the activity of the late acting components as a  group, CJ5, C%, 
and Cr7 were assayed individually and C'8 and Ct9 were assayed together. These assays were 
performed using 2.5 X  l0  T EACtla,4,°Xy2a cells. To quantitate C%, a 1:20 dilution of human 
serum treated with 1 ~  KSCN was used as a reagent (14). 9/zg of purified C'3 was added. C'7 
was assayed in the presence of 9/~g of purified Ct3, 7.5/~g of purified Ct5, and a  moderate 
excess of partially purified C%, C'8, and C'9. The combined activity of Ct8 and C'9 was deter- 
mined in a system containing 9 #g C~3, 7.5 #g Ct5, and a moderate excess of partially purified 
C% and CtT. 
C'6.--Assay for C'6 was performed according to a technique described elsewhere (9). The 
procedure utilizes C%-deficient rabbit serum and EA. 
Inhibition  of Immune Hemolysis by Mouse  Anti-MuB1  or Anti-Human  C'5  Antisera.-- 
Inhibition of hemolytic activity of mouse or human sera by mouse anfi-MuBl was demon- 
strated in the following manner. A series of tubes was set up which contained 0.05 ml human 
serum, diluted 1:4, or 0.05 ml normal mouse plasma, diluted 1:2. To each tube was added 
0.05 ml 0.1 ~  Na~ EDTA and 0.05 ml of diluted A/HeJ anti-MuB1. The final dilution of 
human and mouse serum in the reaction mixture was 1:40 and 1:25, respectively. The reac- 
tion volume was adjusted to 0.3 ml and the reaction mixtures were incubated for 20 rain at 
32°C and for 1 hr at 4°C. Thereafter, l0  s EAC ~la, 4,2a cells in 0.2 ml was added and hemolysis 
determined after 35 min incubation at 32°C. 
Ultracentrifugation.--Density  gradient  ultracentrifugation was  carried  out  according  to 
Kunkel  (15). 
RESULTS 
Immunologic  Relation  Between  MuB1  and  Human  C'5.--Fig.  1  illustrates 
two double diffusion experiments demonstrating  the immunologic  relationship 4  COMPLEMENT  IN  MICE 
between MuB 1 and human C'5. Normal mouse serum and complement-deficient 
mouse serum, human serum and purified human C'5 were reacted with mouse 
anti-MuB1 and mouse  anti-human C'5.  In addition,  the  specificities of  the 
FIG. 1. Ouchterlony plate with diagram illustrating the immunologic relationship between 
MuBI and human C'5.  Center wells: (a)  Mouse anti-MuB1  (obtained from the 40% am- 
monium sulphate precipitate  of an antiserum from I)BA/2J, approximately four times the 
original concentration);  and  (b)  Mouse anti-human C'5  antiserum  (obtained from A/HeJ 
mice). Peripheral wells of (a) and (b): NMS, normal mouse serum from male C57L/J  mice; 
HS,  fresh human serum; C'5,  purified human C'5;  anti-C'5,  rabbit anti-human C'5;  and 
DMS, complement-deficient mouse serum from male A/HeJ mice. 
mouse antisera were also compared with the specificity of a  rabbit anti-human 
C'5. 
The pattern shown in Fig.  1, a  was obtained with the  "y-globulin fraction of 
the  anti-MuB1 antiserum from  DBA/2J mice.  The pattern in Fig.  1,  b was 
obtained with the mouse anti-human C% antiserum. Both antisera gave single ULF R.  NILSSON AND HANS J'. MOLLER-EBERHARD 
precipitin lines when reacted with human and with normal mouse serum. The 
human  and  the  murine  antigens  showed  a  reaction of partial  identity,  the 
homologous precipitin lines  extending marked spurs over the precipitln lines 
corresponding  to  the  cross-reacting  antigens.  The precipitin  line  formed  by 
either of the two mouse antisera with whole human serum fused completely 
with  the  precipitin  line  formed between  these  antisera  and  purified  human 
C~5. That the latter precipitin line corresponded to C~5 and not to an ~mlrnown 
antigen possibly present in C~5 preparations was verified using a  rabbit anti- 
120" 
100"  Whole  Serum  .~- ...... 
80-  , 
t~  Serum  ;~  .~,.~  60- //•  Depleted of C'lq  • 
~40- : 
20" 
4oo  8io  8;o  lo o  12;o 
pl Serum 
FIG. 2. Comparative quantitative precipitin analysis of C'5 in an individual human serum, 
before and after removal of C'lq. Increasing amounts of serum added to a constant amount 
of mouse anti-human  C'5 (0.05 rnl  of the pseudoglobulin fraction obtained from A/HeJ 
mice). Precipitation carried out in the presence of 0.01 K EDTA.  Serum depleted of C'lq 
yielded smaller amounts of precipitate than whole serum, the difference being most pro- 
nounced in the antigen excess zone. 
human  C'5.  No reaction  was observed between  the two mouse antisera and 
complement-deficient mouse  serum.  The precipitin  line  formed between  the 
mouse  antisera  and  rabbit  anti-human  C'5  is  presumably  due  to  a  cross- 
reaction with rabbit C'5. 
It appears, therefore, that antisera developed in complement-deficient mice 
against MuB1  react with the fifth component of human complement. It was 
also  demonstrated  that  antisera  developed  in  complement-deficient  mice 
against purified human C'5 react with MuB1 of normal mouse serum. 
Quantita2i~e Predpitin Analysis  of Human C'5  and MuB1.--Quantitative 
precipitln analysis was utilized to determine the concentration of CP5 in human 
serum and of MuB1 in male and female mouse serum and to study the degree 
of cross-reaction between the two proteins. 
It was anticipated  that  complement would  interfere with  the quantitatlon COMPLEMENT  IN MICE 
of C'5  in fresh serum.  Inactivation of complement by heating the serum  (a 
method frequently employed)  was  not feasible because  this  treatment  was 
found to  abolish the precipitability of human C'5  by specific  antiserum. A 
similar observation was reported by Tachibana and Rosenberg for hc'  (16). 
Instead, all precipifin analyses were performed in the presence of 0.01 K EDTA. 
Although this procedure is known to block the complement reaction, it still 
allows binding of C'lq to immune complexes (I0). The concentration of C'lq in 
human serum is estimated to be of the same order as that of C'5. Since rela- 
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FIG. 3.  Comparative  quantitative  analysis of purified C'5  and  C'5 in serum  depleted  of 
C'lq. Demonstration of cross-reaction between human C'S and MuB1 in normal male mouse 
serum  (C57L/J)  depleted of C'lq.  Antiserum:  mouse  (A/HeJ)  anti-human  C'5. Conditions 
similar  to  those  of  experiment  illustrated in  Fig.  2,  except  that  precipitates  of the  cross- 
reacting antigen were obtained in the presence of constant mounts  (22/zg) of hemolytic~lly 
active, purified human C'lq. No precipitates formed when this analysis was performed in the 
absence of C'lq. 
tively large serum samples were required for the analyses, it was important 
to  estimate  the  effect of  C'lq  on  the  precipitin  reaction  between  C'5  and 
anfi-C'5. 
Fig.  2  shows  quantitation of  C'5  by precipitin  analysis in  whole human 
serum and in serum previously depleted of C'lq. In the presence of C'lq the 
yield of precipitate appears to be slightly larger in antibody excess and con- 
siderably  larger  in  antigen  excess.  Similar  results  were  obtained  when  the 
precipitin reaction was carried out with purified human C'5 in the presence 
and in the absence of purified C'lq. In view of these findings, sera to be ana- 
lyzed for C'5 or MuB1 were depleted of C'lq prior to analysis. Comparative 
analysis of purified  C'5  and  of  C'5  in  C'lq-depleted  serum  yielded similar 
results (Fig. 3). UL~" R.  NILSSON  AND  HANS  J.  M~LLER-EBERHARD 
Using  the precipitin  curve obtained  with  highly  purified  human  C'5  as  a 
standard curve, the concentration of this protein was determined in the serum 
from six different individuals.  As listed in Table I, the  concentration  varied 
between 50 and 86/zg per ml, the mean value being 61  ~g per ml. 
Quantitative precipitin analysis was also applied to the study of the cross- 
reaction between human Ct5 and MuB1. It was found impossible, however, to 
detect precipitates after addition  of varying amounts  of normal male mouse 
serum to the A/HeJ anti-human C'5 antiserum. This was unexpected in view 
of the previously described double diffusion experiment which clearly indicated 
the  presence  in  this  antiserum  of antibodies  cross-reacting  with  MuB1.  To 
TABLE I 
Concentration of C'5 in Human Sara Determined by Quantilative Precipitation* 
Serum No.  Sex 
M 
M 
M 
M 
F 
F 
Determined  in 
C'lq depleted  serum 
~g/ml 
57 
62 
5O 
5O 
63 
86 
Whole serum 
~glml 
75 
Not done 
Not done 
Not done 
75 
Not done 
* Conditions: Antigen precipitated by 0.05 ml mouse anti-human C'5 in a  reaction sys- 
tem of 2.5 ml in presence of 0.01 ~ EDTA. Incubation for 1 hr at 37°C and 5 days at 4°C. 
precipitate soluble antigen-antibody complexes, the experiment was performed 
in  the presence of purified human  C'lq.  Under  such  conditions,  precipitates 
indeed formed. In the experiment illustrated  in Fig. 3, a  constant amount of 
22/zg of hemolytically active C'lq was added to each tube. Maximal precipi- 
tation was obtained with 50 #1 of normal male mouse serum (C57BL/6J). 
In view of Cinader's findings (2)  of sex-related differences in serum concen- 
tration  of MuB1,  precipitin  curves  were  obtained  with  two  male  and  two 
female mouse serum pools using A/HeJ anti-MuB1 antiserum. Fig. 4 illustrates 
the  results.  Two widely  different  precipitin  curves  were  obtained.  Maximal 
precipitation with male serum was obtained after addition  of approximately 
100/zl of serum. To reach the maximal precipitation with female serum, more 
than  twice  the amount of serum  (235  /zl) had  to be added.  In  the  range of 
minimal antigen concentration both curves are similar. However, as the anti- 
gen concentration is increased and equivalence is approached with the serum 
of male origin, the curve obtained with the serum from females levels off and 
reaches a  maximum only at a  considerably higher  serum concentration.  The COMPLEI~ENT IN MIC~'. 
shape  of  the  precipitin  curve  representing  the  reaction with  female  mouse 
serum  suggested either the participation in  the reaction of an antigen unre- 
lated to MuB1 or an immunochemical heterogeneity of MuB1. Participation 
of an  unrelated  antigen was  ruled  out  by the following experiments.  First, 
after removal of the precipitate from the tubes containing equivalent amounts 
of male serum, a suitable volume of female serum (54.#1) was added. No axldi- 
tional precipitate formed. Secondly, after removal of the precipitate from the 
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Fro. 4. Comparative quantitative precipitin analysis of MuB1 in male and  female normal 
mouse serum. Antiserum: 0.2 ml mouse (A/HeJ) anti-MuB1. Conditions similar to those of 
the experiment illustrated in Fig. 2.  Two independent experiments are  recorded.  Maximal 
precipitation for two male serum pools was obtained with approximately half the  amount 
of serum  (100/~1)  necessary to reach precipitation maximum with two female  serum pools 
(235 y,1). 
tubes containing one-quarter the equivalent amount of female serum (53 pl), 
the equivalent amount of male serum (108 #1) was added. Less than 5 #g of 
additional  precipitate  were  obtained,  instead  of  approximately  30  #g  that 
should have formed if the precipitate of female serum in antibody excess was 
due to an  unrelated antigen.  The possibility of an immunochemical hetero- 
geneity of the MuBI protein could not be ruled out on the basis of present 
evidence. 
Re.constitution of Hemolytic  Activity  of Complement-Deficient Mouse Serum 
with Purified Human C'5.--The  antigenic  relationship  between  MuB1  and 
human  C'5  suggested that the two proteins might be analogues with respect 
to their function. Therefore, it was  tested whether the hemolytic activity of 
complement-deficient mouse serum was reconstituted by purified human C'5. ULF  R.  NILSSOlq  AND  HANS  ~.  M'~LLER-EB~ 
Increasing amounts of highly purified human C'5 were added to complement 
deficient serum obtained from male B10.D2/Sn old line mice and the hemolytic 
activity of these mixtures was measured using EAC'la,4, °ZY2a cells and 0.01 
xr EDTA. The results are depicted in Fig. 5  and indicate that human C'5, 
indeed, restores hemolytic activity of serum from complement-deficient male 
mice. The complement-deficient serum reconstituted with 6 #g of human C'5 
had the same hemolytic activity as a similar amount of normal mouse serum 
obtained from maie B10.D2/Sn new line mice. A similarly complete reconstitu- 
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Fzo. 5. Reconstitution  of hemolytic  activity of complement-deficient  mouse plasma with 
increasing amounts of purified human C'5. Reaction system of 0.5 ml contained 0.01 g  EDTA, 
2.5 X  107 EACtla,4,°xY2a cells and mouse serum from B10.D2 old line male mice in a final 
dilutlon of 1:20. Lysis at 32°C for 60 rain. Normal mouse serum from B10.D2 new line male 
mice in the same dilution yielded 35% lysis. 
tion could not be observed, however, with serum from female members of the 
same complement-deficient strain. This difference could be explained by the 
sex-dependent depression  of later acting  complement components in  serum 
from female mice, and it could be dirnlnated by the addition to serum from 
feraale mice of smal amounts of a preparation of human C'6 and C'7. 
Although the data suggest that human C'5  restores hemolytlc activity in 
complement-defident mouse sera, it seemed important to verify the identity 
of  the hemolytically active agent with  the antigen detected by  the mouse 
anti-MuB1. 
Table II demonstrates that mouse anti-MuB1 is capable of inhibiting the 
hemolytic activity of human  serum as it inhibits  the hemolytic activity of 
normal mouse serum. Inhibition obtained with anti-MuB1  was significantly 
larger than that observed with serum of nonlmraunized mice of the same strain. 10  COMPLEMENT  IN  MICE 
The amounts  of human  serum and  of normal mouse plasma were chosen  to 
yield in the absence of antiserum 77 and 23 %  of hemolysis, respectively. 
To verify the specificity of inhibition it was necessary to demonstrate com- 
petition of purified human CP5 for the inhibiting  antibody.  For this purpose, 
the MuB1 antiserum was used in the highest dilution producing 100 % inhibi- 
tion  (1:30  for inhibition  of human  complement and  1:90  for that  of mouse 
plasma). As shown in Tables III and IV, inhibition was overcome with addi- 
tion  of increasing  amounts of purified human  C~5, 5  to 6 #g being sufficient 
for almost complete restoration. Addition of purified C'3 or partially purified 
C'6 and  C'7  had  no  demonstrable  restoring  effect.  Similar  results  were  oh- 
TABLE II 
Inhibition by Mouse Anti-MuB1 of Immune Hemolysis using Human or 
Mouse Complement 
Reciprocal of 
antiserum dilution 
30 
90 
270 
810 
Per cent inhibition  of hemolysis of 108 EAC'Ia,4, 2a cells* 
Human serum 
loo  (16):~ 
51  (12) 
7  (9) 
5  (7) 
Mouse serum 
lOO  (3o) 
lOO  (13) 
61  (9) 
35  (0) 
*Reaction performed in the presence of 0.01 ~t EDTA. 
Numbers placed in parenthesis indicate per cent inhibition of hemolysis observed with 
identical dilutions of serum from nonimmunized mice of the same strain. 
tained  when  the  analogous  experiments were performed with  a  mouse anti- 
human C% antiserum. 
Relative Deficiency  of the Fifth, Sixth, and Seventh Component  of Complement 
in the Serum of Female Mice.--As previously described by others  (2,  6,  17),  a 
considerable  difference in  hemolytic activity was noticed  between  sera from 
normal male and female mice, the latter being consistently less active. Cinader 
et  al.  ascribed  this  difference  to  the  concentration  of MuB1  (Cr5)  which  is 
lower  in  female sera  than in  male sera  (2,  18).  In  the  present  study it  was 
found that the difference in sex-related hemolytic activity is not only due to 
C'5 levels, but  to  a  sex-related difference in  the  concentrations  of C'5,  C'6, 
and C'7. A component analysis (Figs. 6 a-6 d) showed that C'5 levels in serum 
of normal male mice were approximately twice as high as in serum from nor- 
mal female mice (Fig. 6 a). A similarly marked difference between female and 
male sera was found for C'6 (Fig. 6 b) and CP7 (Fig. 6 e). In contrast, C'8 plus 
C~9 levels were not so markedly different in sera from normal male and female 
mice. Further, hemolytic activity of normal female mouse serum was enhanced 
83 % by addition of C'6 and C~7 and was thus increased to a level corresponding ULF  R.  NILSSON  AND  HANS  J.  MULLER-EBERHARD  11 
to 76 % of the activity of male mouse serum. The latter could not be affected 
in a  similar manner. Addition of C'8 did not change the hemolytc activity of 
sera of either male or female origin. Quantitation of C'3 and C'5 by Ouchter- 
lony technique  (19)  revealed the expected concentration difference of MuB1, 
but failed to detect any sex-related concentration difference of C'3. Thus, the 
TABLE III 
Effect of Purified Human C'5 on Inhibition  of Immune Hemolysis by Anti-MuB1 
Using Human Complement* 
C'5  Hemolysis 
~g 
0.0 
0.6 
3.0 
6.0 
% 
0 
28 
78 
100 
* Conditions: (a)  Concentration of human serum, 1:40; dilution of anti-MuB1, 1:30; 
EDTA, 0.01 ~t; time of reaction, 1 hr. (b) Number of EACqa,4,2a cells added, 108; reac- 
tion time at 32°C, 30 rain. 
TABLE IV 
Effect of Purified Human C'5 on Inhibildon of Immune Hemolysis by Anti-MuB1 
Using Mouse Complement* 
Hemolysis, % (human C'6 
C'5  Hemolysis  and C'7 added) 
#g 
0 
0.5 
3.0 
5 
% 
7 
6 
14 
24 
4 
12 
48 
79 
* Conditions: (a)  Concentration of mouse serum, 1:20; dilution  of  anti-MuB1, 1:90; 
EDTA, 0.01 ~; time of reaction, 1 hr. (b) Number of EAC'la,4,2a cells added, 10s; volume 
of C'6, 7 solution, 0.05 ml; reaction time at 32°C, 30 min. 
relative deficiency of sera from female mice is primarily due to lower levels of 
C'5, C%, and C'7. 
DISCUSSION 
Rosenberg and Tachibana demonstrated that certain strains of inbred mice 
were completely devoid of hemolytic complement activity (3).  The data indi- 
cated that a  single gene difference was responsible for the observed variation 
in complement. The gene locus was designated Hc and the alleles determining 
the presence and absence of hemolytic complement activity hc' and hc  °, respec- 12  COMIPLEMIENT IN MICE 
tively (4). Immunization of complement-deficient strains  of mice with serum 
from strains with hemolytic activity led to the formation of antibodies against 
the gene product, designated hc' (1). Similar  observations were independently 
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Fins. 6 a-6 d. Component analysis of normal and complement-deficient male and female 
mouse serum for C'5, C'6, C'7, and C'8 plus C'9. C'5, C'7, and C'8 plus C'9 were assayed in 
0.5  ml containing 0.01 ~  EDTA,  2.5  X  107 EAC'la,4°xY2a cells and  a  source of human 
complement lacking the appropriate component.  C'6 was assayed in 0.3 ml containing C'6 
deficient rabbit serum in 1:30 dilution and 2.5 X  107 EA. Female sera showed markedly lower 
hemolytic activity than male sera when tested for C'5, C'6, and C'7. 
made by Cinader and coworkers (2), who designated the gene product MuB1. 
In addition, the latter workers observed that antisera against MuB1 raised in 
complement-deficlent  strains  of mice  cross-react  with  an  analogous  protein 
present in  the serum of a  wide variety of mammalian  species, including  the 
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The present investigation was initiated when it became apparent that hc', 
or MuB1, resembled  in several  characteristics  a  protein from human serum 
which was recently isolated in this laboratory and identified as the fifth com- 
ponent of human complement (9). Cross-reacting  anti-MuB1 antisera devel- 
oped in complement-deficient  mice offered an ideal tool for the study of the 
antigenic relationship  between MuB1  and human CtS. By the use  of such 
anfisera it was  readily demonstrated that the two proteins  shared common 
antigenic determinants.  In  addition, complement-deficient  mice  immunized 
against human C'5 were found to develop antibodies  which not only reacted 
with  the  homologous  antigen,  but  also  cross-reacted  with MuB1  and  the 
analogous  component in bovine,  horse,  and rabbit serum.  The mouse anti- 
human C'5 failed to react with any serum constituent of complement-deficient 
mice. 
If MuB1 represented  the fifth component of mouse complement,  it should 
be possible to reconstitute complement-deficient mouse serum by addition of 
highly purified  C'5.  Provided that there were no functional incompatibilities 
between human and mouse components, human C'5 should furnish the missing 
activity. Very small amounts of human C'5 did, indeed, render complement- 
deficient  mouse serum hemolytically active.  Furthermore, if the MuB1-C'5 
hypothesis was  correct,  the hemolytic activity of human serum  should  be 
specifically inhibited by mouse anti-MuB1 and that of mouse serum by anti- 
human C'5. In both cases, inhibition should be reversed by addition of purified 
C'5. Each of these postulates was experimentally verified. It was therefore con- 
cluded that mice with an inherited complement deficiency lack the fifth com- 
ponent of complement. 
As  the  immunologic  cross-reaction  between  MuB1  and  human  C'5  was 
readily demonstrable by the Ouchterlony double diffusion technique,  attempts 
were made to estimate the degree of cross-reaction  by the quantitative pre- 
cipitin technique.  The latter method was also used to determine the absolute 
concentration of C'5  in human serum.  Immunochemical quanfitation of C'5 
and of MuB1  in whole  serum,  however,  posed  certain  technical  problems. 
Since these antigens are thermolabile, heating of serum could not be employed 
to inactivate complement.  It was necessary,  therefore,  to find conditions  al- 
lowing the quantitation of the antigen in unheated serum without interference 
by other complement components.  While EDTA is an effective inhibitor of 
the complement system, it does not prevent Cqq from combining with antigen- 
antibody complexes  (10). Cqq  was,  therefore,  removed from all sera  to be 
analyzed, using  a  method described  earlier  (10), and the precipitin analysis 
was carried out in the presence of 0.01 M EDTA. This measure afforded a pre- 
cise quantitation of C'5-protein in individual human sera.  Reference  values 
were obtalned using highly purified human C'5. 
Although the Ouchterlony technique permitted demonstration of the cross- 14  COMPLEMENT  IN  MICE 
reaction between MuB1 and human C'5, no precipitate formed when a  quan- 
titative  precipitin  analysis  was  performed on  normal,  C'lq-depleted  mouse 
serum using mouse anti-human C'5. However, when purified human C'lq was 
added  to the reaction mixtures, small amounts of precipitate were obtained. 
Obviously, antigen-antibody complexes had formed but stayed in solution in 
the absence of C'lq.  The high solubility of the complexes indicates either a 
low affinity of the cross-reacting antibody or the presence on the mouse anti- 
gen of a  rather  limited number of determinants,  possibly fewer than  three, 
that  can be recognized by the antibody to human  C'5.  On  the basis  of the 
precipitin curves depicted in Fig. 3, the degree of cross-reaction between MuB1 
and human C'5 was estimated to be less  than 15 %. The conditions prevailing 
in  agar  gels  are  apparently  more  favorable for  the  manifestation  of  weak 
precipitation reactions. 
Another aspect of these investigations concerns sex-related variations of C'5 
levels and of certain other complement components. The human sera differed 
little in C'5 concentration regardless of sex. However, striking differences were 
found in normal mouse sera. In agreement with Cinader's et al. observations 
(2), female mice were found to have approximately half the serum  C'5  con- 
centration of male mice. In addition to this quantitative difference, a  qualita- 
tive difference between  the  precipitin curves for MuB1  of male and  female 
origin  became  apparent,  which  may  be  indicative  of  an  immunochemical 
heterogeneity of MuB1. In accordance with the quantitative precipitin data, 
C'5 hemolytic activity was found to be appreciably lower in sera from female 
mice than in those of male mice. However, the relative deficiency of this com- 
ponent did not fully explain the low overall hemolytic activity invariably en- 
countered with sera from female mice. Addition of purified human C'5 did not 
raise the activity to the higher level of serum from male mice. This could be 
achieved, however, by addition of C'6 and  C'7 of human origin. Component 
analysis provided additional  evidence for low hemolytic activity of C'6 and 
C'7 in female mouse serum.  By contrast,  C'8 and  C'9 did not seem to differ 
significantly in sera originating from mice of different sex. The data, therefore, 
suggest that the lower hemolytic activity of sera from normal female mice is 
due to a relative deficiency of the activity of C'5, C'6, and Cr7. It is suggested 
that  these three components are primarily involved in  the  recently encoun- 
tered changes of overall complement activity following administration of sex 
hormones to mice (17, 20). 
SUMMARY 
The inherited complement deficiency of certain inbred strains of mice was 
shown to be due to an isolated lack of the fifth component of complement. The 
protein MuB1  (or hc'), which is present in normal mouse serum but absent 
from  the  serum  of  complement-deficient mice,  was  shown  to  be  immuno- ULF R.  NILSSON AND HANS J.  M-ULLER-EBERS.ARD  15 
chemically related  to  the fifth component of human  complement (C'5).  C% 
hemolytic activity was specifically inhibited  in human serum by mouse anti- 
MuB1 and in normal mouse serum by mouse antiserum to human C~5. Highly 
purified  human  C~5  reconstituted  the  hemolytic  activity  of  complement- 
deficient mouse serum. It was,  therefore,  concluded  that hc', or MuB1,  con- 
stitutes the murine analogue of the fifth component of human complement. 
The MuB1  concentration in normal mouse serum was found to be subject 
to a  sex-related variation.  By quantitative precipitin analysis it was demon- 
strated that serum from male mice contains  twice as much MuB1  as that of 
female mice. This difference in C'5 concentration was also detected by hemo- 
lytic assay.  In addition,  C% and  C~7  were  also found  to be subject  to  sex- 
related variations. 
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